 | • レポートコード：MRC2307A0058 • 出版社/出版日：Transparency Market Research / 2023年4月 • レポート形態：英文、PDF、194ページ • 納品方法：Eメール • 産業分類：バイオ |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当市場調査書によると、世界のC反応性タンパク質検査市場規模が、2023年の31億ドルから2031年までに40億ドルに達し、予測期間中にCAGR（年平均成長率）2.9%で拡大すると予想されています。本書は、C反応性タンパク質検査の世界市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、検査別（一般C反応性タンパク質検査、高感度C反応性タンパク質）分析、分析別（ELISA、免疫比濁法、免疫クロマトグラフィー法、免疫蛍光法、その他）分析、疾患別（心臓疾患、炎症性疾患、感染症、その他）分析、エンドユーザー別（病院関連研究所、独立診断研究所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの項目を掲載しています。なお、Agilent Technologies, Inc.、Laboratory Corporation of America Holdings、Thermo Fisher Scientific、Abbott Laboratories、F. Hoffmann-La Roche Ltd.、Creative Diagnostics、DxGen Corp.、CTK Biotech, Inc.、Getein Biotech, Inc.、Goldsite Diagnostics, Inc.、OptiBio Co., Ltd.、Nanjing Vazyme Biotech Co., Ltd.など、主要企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・世界のC反応性タンパク質検査市場規模：検査別 - 一般C反応性タンパク質検査の市場規模 - 高感度C反応性タンパク質の市場規模 ・世界のC反応性タンパク質検査市場規模：分析別 - ELISAにおける市場規模 - 免疫比濁法における市場規模 - 免疫クロマトグラフィー法における市場規模 - 免疫蛍光法における市場規模 - その他分析における市場規模 ・世界のC反応性タンパク質検査市場規模：疾患別 - 心臓疾患における市場規模 - 炎症性疾患における市場規模 - 感染症における市場規模 - その他疾患における市場規模 ・世界のC反応性タンパク質検査市場規模：エンドユーザー別 - 病院関連研究所における市場規模 - 独立診断研究所における市場規模 - その他エンドユーザーにおける市場規模 ・世界のC反応性タンパク質検査市場規模：地域別 - 北米のC反応性タンパク質検査市場規模 - ヨーロッパのC反応性タンパク質検査市場規模 - アジア太平洋のC反応性タンパク質検査市場規模 - 中南米のC反応性タンパク質検査市場規模 - 中東・アフリカのC反応性タンパク質検査市場規模 ・競争状況 |
C-Reactive Protein Testing Market – Scope of Report
TMR’s report on the global C-Reactive Protein Testing Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global C-Reactive Protein Testing Market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global C-Reactive Protein Testing Market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Plasmonic Materials market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Plasmonic Materials market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Plasmonic Materials market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Plasmonic Materials market.
The report delves into the competitive landscape of the global Plasmonic Materials market. Key players operating in the global C-Reactive Protein Testing Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global C-Reactive Protein Testing Market profiled in this report.
Key Questions Answered in Global C-Reactive Protein Testing Market Report
• What is the sales/revenue generated by Plasmonic Materials across all regions during the forecast period?
• What are the opportunities in the global Plasmonic Materials market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
C-Reactive Protein Testing Market – Research Objectives and Research Approach
The comprehensive report on the global C-Reactive Protein Testing Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global C-Reactive Protein Testing Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Plasmonic Materials market.”
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global C-reactive Protein Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global C-reactive Protein Testing Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Overview of C-reactive Protein Testing Market
5.2. Key Product/ Brand Analysis
5.3. Pipeline Analysis
5.4. COVID-19 Pandemic Impact on Industry
6. Global C-reactive Protein Testing Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Test Type, 2017–2031
6.3.1. Standard C-reactive Protein Test
6.3.2. High-sensitivity C-reactive Protein (hs-CRP) Test
6.4. Market Attractiveness Analysis, by Test Type
7. Global C-reactive Protein Testing Market Analysis and Forecast, by Type of Assay
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Type of Assay, 2017–2031
7.3.1. ELISA
7.3.2. Immunoturbidimetry
7.3.3. Immuno-chromatography
7.3.4. Immunofluorescence
7.3.5. Others
7.4. Market Attractiveness Analysis, by Type of Assay
8. Global C-reactive Protein Testing Market Analysis and Forecasts, by Indication
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Indication, 2017–2031
8.3.1. Heart Diseases
8.3.2. Inflammatory Diseases
8.3.3. Infectious Diseases
8.3.4. Others
8.4. Market Attractiveness Analysis, by Indication
9. Global C-reactive Protein Testing Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospital Associated Laboratories
9.3.2. Independent Diagnostic Laboratories
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global C-reactive Protein Testing Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America C-reactive Protein Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Test Type, 2017–2031
11.2.1. Standard C-reactive Protein Test
11.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
11.3. Market Value Forecast, by Type of Assay, 2017–2031
11.3.1. ELISA
11.3.2. Immunoturbidimetry
11.3.3. Immuno-chromatography
11.3.4. Immunofluorescence
11.3.5. Others
11.4. Market Value Forecast, by Indication, 2017–2031
11.4.1. Heart Diseases
11.4.2. Inflammatory Diseases
11.4.3. Infectious Diseases
11.4.4. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospital Associated Laboratories
11.5.2. Independent Diagnostic Laboratories
11.5.3. Others
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Test Type
11.7.2. By Type of Assay
11.7.3. By Indication
11.7.4. By End-user
11.7.5. By Country
12. Europe C-reactive Protein Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Test Type, 2017–2031
12.2.1. Standard C-reactive Protein Test
12.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
12.3. Market Value Forecast, by Type of Assay, 2017–2031
12.3.1. ELISA
12.3.2. Immunoturbidimetry
12.3.3. Immuno-chromatography
12.3.4. Immunofluorescence
12.3.5. Others
12.4. Market Value Forecast, by Indication, 2017–2031
12.4.1. Heart Diseases
12.4.2. Inflammatory Diseases
12.4.3. Infectious Diseases
12.4.4. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospital Associated Laboratories
12.5.2. Independent Diagnostic Laboratories
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Test Type
12.7.2. By Type of Assay
12.7.3. By Indication
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific C-reactive Protein Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Test Type, 2017–2031
13.2.1. Standard C-reactive Protein Test
13.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
13.3. Market Value Forecast, by Type of Assay, 2017–2031
13.3.1. ELISA
13.3.2. Immunoturbidimetry
13.3.3. Immuno-chromatography
13.3.4. Immunofluorescence
13.3.5. Others
13.4. Market Value Forecast, by Indication, 2017–2031
13.4.1. Heart Diseases
13.4.2. Inflammatory Diseases
13.4.3. Infectious Diseases
13.4.4. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospital Associated Laboratories
13.5.2. Independent Diagnostic Laboratories
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Test Type
13.7.2. By Type of Assay
13.7.3. By Indication
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America C-reactive Protein Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Test Type, 2017–2031
14.2.1. Standard C-reactive Protein Test
14.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
14.3. Market Value Forecast, by Type of Assay, 2017–2031
14.3.1. ELISA
14.3.2. Immunoturbidimetry
14.3.3. Immuno-chromatography
14.3.4. Immunofluorescence
14.3.5. Others
14.4. Market Value Forecast, by Indication, 2017–2031
14.4.1. Heart Diseases
14.4.2. Inflammatory Diseases
14.4.3. Infectious Diseases
14.4.4. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospital Associated Laboratories
14.5.2. Independent Diagnostic Laboratories
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Test Type
14.7.2. By Type of Assay
14.7.3. By Indication
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa C-reactive Protein Testing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Test Type, 2017–2031
15.2.1. Standard C-reactive Protein Test
15.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
15.3. Market Value Forecast, by Type of Assay, 2017–2031
15.3.1. ELISA
15.3.2. Immunoturbidimetry
15.3.3. Immuno-chromatography
15.3.4. Immunofluorescence
15.3.5. Others
15.4. Market Value Forecast, by Indication, 2017–2031
15.4.1. Heart Diseases
15.4.2. Inflammatory Diseases
15.4.3. Infectious Diseases
15.4.4. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospital Associated Laboratories
15.5.2. Independent Diagnostic Laboratories
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Test Type
15.7.2. By Type of Assay
15.7.3. By Indication
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Agilent Technologies, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Laboratory Corporation of America Holdings
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Thermo Fisher Scientific
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Abbott Laboratories
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. F. Hoffmann-La Roche Ltd.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Creative Diagnostics
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. DxGen Corp
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. CTK Biotech, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Getein Biotech, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Goldsite Diagnostics, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. OptiBio Co., Ltd.
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. Nanjing Vazyme Biotech Co., Ltd.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
Table 01: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 02: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017‒2031
Table 03: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 04: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 05: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 08: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017‒2031
Table 09: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 10: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 13: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017‒2031
Table 14: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 15: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 18: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017‒2031
Table 19: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 20: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 23: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017‒2031
Table 24: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 25: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 27: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031
Table 28: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017‒2031
Table 29: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 30: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031